Generic Videx EC approved for treatment of HIV - MPR
Links shared publicly online about this topic.
- 1,229total visits
Generic Videx EC approved for treatment of HIV - MPR
empr.com —
View full resource at empr.com
Tags: HIV, HIV Medication, STD, Drug, FDA, Videx, News
Most Recently Shared on April 19, 2010 at 5:16 pm By:
MPR News: Generic Videx EC approved for treatment of HIV: Mylan announced that the FDA has approved its Abbreviate... http://bit.ly/dbPfSl
Mylan Announces Approval Under PEPFAR For Generic Version Of Videx(R) EC HIV Treatment
medicalnewstoday.com — “Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan” View full resource at medicalnewstoday.com
Most Recently Shared on April 22, 2010 at 2:09 pm By:
Mylan Announces Approval Under PEPFAR For Generic Version Of Videx(R) EC HIV Treatment http://mnt.to/3BBw #hivaids
Generic Videx EC approved for treatment of HIV - ONA
oncologynurseadvisor.com — “Mylan announced that the FDA has approved its Abbreviated New Drug Application (ANDA) for didanosine delayed-release capsules, the generic version of Videx EC (from Bristol Myers Squibb).” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 19, 2010 at 4:30 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Generic Videx EC approved for treatment of HIV http://goo.gl/fb/vXjZ3
Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR
news-medical.net — “Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.” View full resource at news-medical.net
Most Recently Shared on April 19, 2010 at 1:35 pm By:
Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR: Mylan Inc. t... http://bit.ly/cxh5Cs
Advertisement
